The Efficacy and Tolerability of CV 205–502 (a Nonergot Dopaminergic Drug) in Macroprolactinoma Patients and in Prolactinoma Patients Intolerant to Bromocriptine (Q44023416)
Jump to navigation
Jump to search
scientific article published on May 1, 1991
Language | Label | Description | Also known as |
---|---|---|---|
English | The Efficacy and Tolerability of CV 205–502 (a Nonergot Dopaminergic Drug) in Macroprolactinoma Patients and in Prolactinoma Patients Intolerant to Bromocriptine |
scientific article published on May 1, 1991 |
Statements
1 reference
The Efficacy and Tolerability of CV 205–502 (a Nonergot Dopaminergic Drug) in Macroprolactinoma Patients and in Prolactinoma Patients Intolerant to Bromocriptine (English)
1 reference
The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine (English)
1 reference
1 reference
van der Lely AJ
1 reference
A. J. van der Lely
J. Brownell
1 May 1991
1 reference
1 reference
72
1 reference
5
1 reference
1136-1141
1 reference
Identifiers
1 reference
1 reference